liver

FEATURED PUBLICATION

Featured Publication in the ScienceDirect Journal by Dr. Bustamante, Luis O. Chavez, MD, and Marc J. Zuckerman MD.

Endoscopic Bariatric Interventions in Patients with Chronic Liver Disease

Key points

• Endoscopic bariatric interventions are effective in treating obesity and associated comorbidities, including chronic liver disease secondary to metabolic associated fatty liver disease (MAFLD).
•  All endoscopic bariatric interventions should be used concomitantly with moderate- to high-intensity lifestyle modifications in patients in whom conventional weight-loss strategies have failed.
•  Gastric endoscopic bariatric interventions, in particular, intragastric balloons, have demonstrated to be effective in improving liver-related outcomes.
•  Small bowel endoscopic bariatric interventions have had positive results for the treatment of obesity and associated comorbidities, including MAFLD.
•  There is a lack of studies in the setting of cirrhosis and liver transplantation.